VERU INC has a total of 14 patent applications. It increased the IP activity by 1000.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SHIRE PHARMACEUTICALS INC, Mindlab LLC and FORWARD PHARMA AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | France | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mitchell S Steiner | 6 |
#2 | Ravi Kacker | 6 |
#3 | Kacker Ravi | 5 |
#4 | Steiner Mitchell S | 5 |
#5 | Bird Thomas G | 1 |
#6 | Cerro Andrew Michael | 1 |
#7 | Lin Jui-Chen | 1 |
#8 | Barnette Gary K | 1 |
#9 | Rhodes Christopher A | 1 |
#10 | Phelps Kenneth V | 1 |
Publication | Filing date | Title |
---|---|---|
US2020282008A1 | COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS | |
EP3473245A1 | Controlled release oral tamsulosin hydrochloride | |
FR3082842A1 | Cis-clomiphene (zuclomiphene) polymorph and methods of use thereof | |
KR20190110567A | Compositions and methods for long-term release of gonadotropin-releasing hormone (GnRH) antagonists | |
EP3473244A1 | Controlled release oral tamsulosin hydrochloride |